Company Profile
Torque Therapeutics
Company Overview
Torque Therapeutics is developing a new class of Deep-Primed™ T cell therapeutics to dramatically expand cell therapy cures for cancer. Our Deep-Priming technology platforms generate T cells that target multiple tumor antigens and pharmacologically activate an immune response with anchored cytokines. In hematologic cancers, this new class of immune cell therapeutics has the potential to improve on the initial success of single-target CAR T therapeutics with expanded efficacy, and also move cell therapy treatment out of the hospital with a high margin of safety. For solid tumors, Deep-Primed T cells have the potential to enable efficacy against tumors with heterogeneous antigens protected by hostile microenvironments, which are not readily addressable with the first generation of immune cell therapies.
Considering a career at Torque?
We believe that working in multidisciplinary teams is essential to innovation. We have diverse backgrounds in immunology, protein engineering, nanoparticle engineering, computational biology, drug development, and medicine (just to name a few). We are always looking for talented individuals with an entrepreneurial spirit.